Pediatric and adult patients experienced noninferior and robust immune responses to RIV4, as well as similar safety profiles.

Monoclonal antibodies are fundamental to modern biomedical research, therapeutic development, and diagnostic applications.

Logical Biological launches sister company, Logical Antigen, delivering high-quality antigens and biologicals for in vitro ...

The U.S. Food and Drug Administration has approved a prefilled syringe presentation of Shingrix (zoster vaccine recombinant, ...

Sarepta CEO Doug Ingram said it is important the company maintains a “positive working relationship” with the FDA.

Osaka: Takeda has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for HyHub and HyHub ...

In recent weeks, Asian markets have shown resilience with the CSI 300 Index and Shanghai Composite Index posting gains, despite ongoing challenges such as China's persistent deflation pressures and a ...

Protalix BioTherapeutics Inc., a biopharmaceutical company, has appointed Gilad Mamlok as Senior Vice President and Chief ...

NII, is developing AdFalciVax—India’s first recombinant chimeric malaria vaccine. It targets two key stages of Plasmodium falciparum, showing strong preclinical efficacy and extended thermal stability ...

With his three decades of experience in healthcare and technology companies, Gilad will play a pivotal role in the execution of our growth strategy, and I am delighted to welcome him to the Protalix ...

Sarepta Therapeutics said it will voluntarily “and temporarily” pause all shipments of Elevidys® (delandistrogene ...

Semaglutide has surged in popularity over the past two years, thanks to its remarkable effectiveness as a long-acting GLP-1 ...